{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:08:36Z","timestamp":1786374516866,"version":"build-2736575974"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Biosci."],"abstract":"<jats:p>\n                    Bladder cancer is characterized by a highly dynamic tumor microenvironment (TME) that critically influences tumor progression, immune evasion, and therapeutic responsiveness. Among the immune populations in the TME, regulatory T cells (Tregs) play a central role in maintaining immune tolerance but also suppress effective antitumor immunity. Increasing evidence suggests that Tregs accumulate in bladder tumors and are associated with disease progression and reduced response to immunotherapies. The bladder cancer TME provides multiple signals that promote Treg recruitment, expansion, and functional stabilization, including chemokine-mediated trafficking, metabolic adaptation, and cytokine-driven differentiation. Interactions between Tregs and other microenvironmental components, such as cancer-associated fibroblasts, tumor-associated macrophages, endothelial cells, and extracellular matrix elements, further reinforce the immunosuppressive niche that facilitates tumor survival and therapy resistance. Recent advances in single-cell transcriptomics, spatial profiling, and multiomics analyses have revealed substantial heterogeneity among tumor-infiltrating Tregs, suggesting the existence of specialized subsets with distinct functional and metabolic properties in the bladder TME. These emerging insights highlight the importance of understanding Treg\u2013TME crosstalk in shaping the immune landscape of bladder cancer. Targeting the mechanisms regulating Treg recruitment, stability, or suppressive function may represent a promising strategy to enhance the efficacy of immunotherapies including\n                    <jats:italic>Bacillus<\/jats:italic>\n                    Calmette\u2013Gu\u00e9rin therapy. This review summarizes recent advances in Treg biology in bladder cancer and highlights potential therapeutic strategies to modulate Treg-mediated immunosuppression in the TME.\n                  <\/jats:p>","DOI":"10.3389\/fmolb.2026.1898769","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:00:17Z","timestamp":1786370417000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Regulatory T cells in the bladder cancer tumor microenvironment: mechanisms of immune suppression and therapeutic opportunities"],"prefix":"10.3389","volume":"13","author":[{"given":"Yusuke","family":"Fukiage","sequence":"first","affiliation":[{"name":"Department of Urology, Faculty of Medical Sciences, University of Fukui","place":["Fukui, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nodoka","family":"Okubo","sequence":"additional","affiliation":[{"name":"Department of Urology, Faculty of Medical Sciences, University of Fukui","place":["Fukui, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minekatsu","family":"Taga","sequence":"additional","affiliation":[{"name":"Department of Urology, Faculty of Medical Sciences, University of Fukui","place":["Fukui, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, Head and Neck Surgery, Faculty of Medical Sciences, University of Fukui","place":["Fukui, Japan"]},{"name":"Immunology and Allergy Research Unit, Department of Otorhinolaryngology, Head and Neck Surgery, Faculty of Medical Sciences, University of Fukui","place":["Fukui, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Terada","sequence":"additional","affiliation":[{"name":"Department of Urology, Faculty of Medical Sciences, University of Fukui","place":["Fukui, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"268 e9","DOI":"10.1016\/j.urolonc.2024.11.017","article-title":"FOXP3\/TLS; a prognostic marker in patients with bladder carcinoma without muscle invasion","volume":"43","author":"Balcik","year":"2025","journal-title":"Urol. Oncol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1275375","DOI":"10.3389\/fimmu.2023.1275375","article-title":"Targeting myeloid-derived suppressor cells with gemcitabine to enhance efficacy of adoptive cell therapy in bladder cancer","volume":"14","author":"Bazargan","year":"2023","journal-title":"Front. Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/nature12965","article-title":"Comprehensive molecular characterization of urothelial bladder carcinoma","volume":"507","year":"2014","journal-title":"Nature."},{"key":"B4","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.eururo.2018.06.045","article-title":"Conventional and PD-L1-expressing regulatory T cells are enriched during BCG therapy and May limit its efficacy","volume":"74","author":"Chevalier","year":"2018","journal-title":"Eur. Urol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/j.1365-2249.2010.04215.x","article-title":"Involvement of T helper type 17 and regulatory T cell activity in tumour immunology of bladder carcinoma","volume":"161","author":"Chi","year":"2010","journal-title":"Clin. Exp. Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1016\/s0140-6736(22)01188-6","article-title":"Current best practice for bladder cancer: a narrative review of diagnostics and treatments","volume":"400","author":"Comperat","year":"2022","journal-title":"Lancet."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1016\/S0140-6736(25)01897-5","article-title":"Durvalumab in combination with BCG for BCG-naive, high-risk, non-muscle-invasive bladder cancer (POTOMAC): final analysis of a randomised, open-label, phase 3 trial","volume":"406","author":"De Santis","year":"2025","journal-title":"Lancet"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.immuni.2016.10.021","article-title":"Transcriptional landscape of human tissue lymphocytes unveils uniqueness of tumor-infiltrating T regulatory cells","volume":"45","author":"De Simone","year":"2016","journal-title":"Immunity"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1084\/jem.20062512","article-title":"Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression","volume":"204","author":"Deaglio","year":"2007","journal-title":"J. Exp. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","article-title":"Bladder cancer","volume":"9","author":"Dyrskjot","year":"2023","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B11","doi-asserted-by":"publisher","first-page":"622995","DOI":"10.3389\/fimmu.2021.622995","article-title":"Natural killer anti-tumor activity can be achieved by in vitro incubation with heat-killed BCG","volume":"12","author":"Esteso","year":"2021","journal-title":"Front. Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1001\/jama.2011.1142","article-title":"Association between smoking and risk of bladder cancer among men and women","volume":"306","author":"Freedman","year":"2011","journal-title":"JAMA"},{"key":"B13","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1111\/iju.70044","article-title":"Peritumoral infiltration of regulatory T cells reduces the therapeutic efficacy of bacillus calmette-guerin therapy for bladder carcinoma in situ","volume":"32","author":"Fukiage","year":"2025","journal-title":"Int. J. Urol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/s00262-026-04400-4","article-title":"CD39\/CD73-mediated immunosuppression and tumor aggressiveness in bladder cancer","volume":"75","author":"Furriel","year":"2026","journal-title":"Cancer Immunol. Immunother."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1084\/jem.20051511","article-title":"CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner","volume":"202","author":"Ghiringhelli","year":"2005","journal-title":"J. Exp. Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.celrep.2017.06.079","article-title":"An Atlas of human regulatory T helper-like cells reveals features of Th2-like tregs that support a tumorigenic environment","volume":"20","author":"Halim","year":"2017","journal-title":"Cell. Rep."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science"},{"key":"B18","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00345-015-1615-3","article-title":"The prognostic effect of tumour-infiltrating lymphocytic subpopulations in bladder cancer","volume":"34","author":"Horn","year":"2016","journal-title":"World J. Urol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e2312855121","DOI":"10.1073\/pnas.2312855121","article-title":"Tumor-neutrophil cross talk orchestrates the tumor microenvironment to determine the bladder cancer progression","volume":"121","author":"Jing","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.3389\/fonc.2019.01270","article-title":"Immune responses in bladder cancer-role of immune cell populations, prognostic factors and therapeutic implications","volume":"9","author":"Joseph","year":"2019","journal-title":"Front. Oncol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.eururo.2019.09.006","article-title":"A Consensus molecular classification of muscle-invasive bladder cancer","volume":"77","author":"Kamoun","year":"2020","journal-title":"Eur. Urol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1158\/1078-0432.CCR-19-1920","article-title":"Adaptive immune resistance to intravesical BCG in non-muscle invasive bladder cancer: implications for prospective BCG-Unresponsive trials","volume":"26","author":"Kates","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e2114282119","DOI":"10.1073\/pnas.2114282119","article-title":"CCR8-targeted specific depletion of clonally expanded Treg cells in tumor tissues evokes potent tumor immunity with long-lasting memory","volume":"119","author":"Kidani","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1182\/blood-2008-01-133967","article-title":"Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells","volume":"112","author":"Koenen","year":"2008","journal-title":"Blood"},{"key":"B25","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12967-023-03949-3","article-title":"Tumor-associated macrophages and tregs influence and represent immune cell infiltration of muscle-invasive bladder cancer and predict prognosis","volume":"21","author":"Koll","year":"2023","journal-title":"J. Transl. Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"615091","DOI":"10.3389\/fimmu.2020.615091","article-title":"Immunological hallmarks for clinical response to BCG in bladder cancer","volume":"11","author":"Lim","year":"2020","journal-title":"Front. Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1084\/jem.20060772","article-title":"CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells","volume":"203","author":"Liu","year":"2006","journal-title":"J. Exp. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"6740","DOI":"10.1038\/s41467-022-34495-z","article-title":"Single cell sequencing reveals that CD39 inhibition mediates changes to the tumor microenvironment","volume":"13","author":"Liu","year":"2022","journal-title":"Nat. Commun."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1158\/2326-6066.CIR-18-0751","article-title":"CCR4 blockade depletes regulatory T cells and prolongs survival in a canine model of bladder cancer","volume":"7","author":"Maeda","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.immuni.2019.02.013","article-title":"Treg-cell control of a CXCL5-IL-17 inflammatory axis promotes hair-follicle-stem-cell differentiation during skin-barrier repair","volume":"50","author":"Mathur","year":"2019","journal-title":"Immunity"},{"key":"B31","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.eururo.2025.11.009","article-title":"The bladder tumor microenvironment is a dynamic ecosystem: how microbes, immunity, and cancer converge","volume":"89","author":"McConkey","year":"2026","journal-title":"Eur. Urol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.3390\/ijms18102186","article-title":"Regulatory T cells and tumor-associated macrophages in the tumor microenvironment in non-muscle invasive bladder cancer treated with intravesical bacille calmette-Guerin: a long-term Follow-Up Study of a Japanese cohort","volume":"18","author":"Miyake","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.immuni.2009.03.019","article-title":"Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor","volume":"30","author":"Miyara","year":"2009","journal-title":"Immunity"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e0204745","DOI":"10.1371\/journal.pone.0204745","article-title":"Prediction of intravesical recurrence of non-muscle-invasive bladder cancer by evaluation of intratumoral Foxp3+ T cells in the primary transurethral resection of bladder tumor specimens","volume":"13","author":"Murai","year":"2018","journal-title":"PLoS One"},{"key":"B35","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/bju.70085","article-title":"Risk of metachronous upper tract urothelial carcinoma following non-muscle-invasive bladder cancer","volume":"137","author":"Pace","year":"2026","journal-title":"BJU Int."},{"key":"B36","doi-asserted-by":"publisher","first-page":"66849","DOI":"10.18632\/oncotarget.19913","article-title":"PD-L1 expression in bladder cancer and metastasis and its influence on oncologic outcome after cystectomy","volume":"8","author":"Pichler","year":"2017","journal-title":"Oncotarget"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1093\/jnci\/djq214","article-title":"Bladder cancer mortality of workers exposed to aromatic amines: a 58-year follow-up","volume":"102","author":"Pira","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"key":"B38","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41571-022-00620-6","article-title":"Clinical relevance of tumour-associated macrophages","volume":"19","author":"Pittet","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/j.immuni.2016.10.032","article-title":"Regulatory T cells exhibit distinct features in human breast cancer","volume":"45","author":"Plitas","year":"2016","journal-title":"Immunity"},{"key":"B40","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.annonc.2024.03.001","article-title":"ESMO clinical Practice Guideline interim update on first-line therapy in advanced urothelial carcinoma","volume":"35","author":"Powles","year":"2024","journal-title":"Ann. Oncol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nrurol.2014.15","article-title":"The mechanism of action of BCG therapy for bladder cancer--a current perspective","volume":"11","author":"Redelman-Sidi","year":"2014","journal-title":"Nat. Rev. Urol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.cell.2017.09.007","article-title":"Comprehensive molecular characterization of muscle-invasive bladder cancer","volume":"171","author":"Robertson","year":"2017","journal-title":"Cell."},{"key":"B43","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/nm.4086","article-title":"Two FOXP3(+)CD4(+) T cell subpopulations distinctly control the prognosis of colorectal cancers","volume":"22","author":"Saito","year":"2016","journal-title":"Nat. Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J. Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.3390\/biomedicines13051173","article-title":"The role of tregs in the tumor microenvironment","volume":"13","author":"Sato","year":"2025","journal-title":"Biomedicines"},{"key":"B46","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3389\/fimmu.2012.00051","article-title":"Molecular mechanisms of treg-mediated T cell suppression","volume":"3","author":"Schmidt","year":"2012","journal-title":"Front. Immunol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"e1338","DOI":"10.1002\/ctm2.1338","article-title":"Integrated single-cell and spatial transcriptomic profiling reveals higher intratumour heterogeneity and epithelial-fibroblast interactions in recurrent bladder cancer","volume":"13","author":"Shi","year":"2023","journal-title":"Clin. Transl. Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1158\/2326-6066.CIR-15-0274","article-title":"Molecular drivers of the Non-T-cell-Inflamed tumor microenvironment in urothelial bladder cancer","volume":"4","author":"Sweis","year":"2016","journal-title":"Cancer Immunol. Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur. Urol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.ccell.2023.02.014","article-title":"Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy","volume":"41","author":"Tay","year":"2023","journal-title":"Cancer Cell."},{"key":"B51","doi-asserted-by":"publisher","first-page":"e001749","DOI":"10.1136\/jitc-2020-001749","article-title":"Therapeutic depletion of CCR8(+) tumor-infiltrating regulatory T cells elicits antitumor immunity and synergizes with anti-PD-1 therapy","volume":"9","author":"Van Damme","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"B52","doi-asserted-by":"publisher","first-page":"793964","DOI":"10.3389\/fimmu.2021.793964","article-title":"The tumor immune landscape and architecture of tertiary lymphoid structures in urothelial cancer","volume":"12","author":"van Dijk","year":"2021","journal-title":"Front. Immunol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"eabn6173","DOI":"10.1126\/sciimmunol.abn6173","article-title":"PD-L1 checkpoint blockade promotes regulatory T cell activity that underlies therapy resistance","volume":"8","author":"van Gulijk","year":"2023","journal-title":"Sci. Immunol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"4793","DOI":"10.1073\/pnas.0900408106","article-title":"Identification of IL-17-producing FOXP3+ regulatory T cells in humans","volume":"106","author":"Voo","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1007\/s00262-020-02583-y","article-title":"CCR8 blockade primes anti-tumor immunity through intratumoral regulatory T cells destabilization in muscle-invasive bladder cancer","volume":"69","author":"Wang","year":"2020","journal-title":"Cancer Immunol. Immunother."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1111\/j.1464-410X.2010.10020.x","article-title":"FOXP3 and survival in urinary bladder cancer","volume":"108","author":"Winerdal","year":"2011","journal-title":"BJU Int."},{"key":"B57","doi-asserted-by":"publisher","first-page":"105176","DOI":"10.1016\/j.ebiom.2024.105176","article-title":"TGF-Beta signalling limits effector function capacity of NK cell anti-tumour immunity in human bladder cancer","volume":"104","author":"Wong","year":"2024","journal-title":"EBioMedicine"},{"key":"B58","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41590-018-0051-0","article-title":"Single-cell gene expression reveals a landscape of regulatory T cell phenotypes shaped by the TCR","volume":"19","author":"Zemmour","year":"2018","journal-title":"Nat. Immunol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s13046-023-02900-0","article-title":"Cancer-associated fibroblasts-derived CXCL12 enhances immune escape of bladder cancer through inhibiting P62-mediated autophagic degradation of PDL1","volume":"42","author":"Zhang","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."}],"container-title":["Frontiers in Molecular Biosciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2026.1898769\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:00:18Z","timestamp":1786370418000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2026.1898769\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":59,"alternative-id":["10.3389\/fmolb.2026.1898769"],"URL":"https:\/\/doi.org\/10.3389\/fmolb.2026.1898769","relation":{},"ISSN":["2296-889X"],"issn-type":[{"value":"2296-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]},"article-number":"1898769"}}